| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 21.61▲ | 21.59▲ | 21.57▲ | 22.11▼ | 21.55▲ |
| MA10 | 21.64▲ | 21.57▲ | 21.73▼ | 22.67▼ | 20.99▲ |
| MA20 | 21.57▲ | 21.81▼ | 21.98▼ | 22.19▼ | 21.81▼ |
| MA50 | 21.58▲ | 22.07▼ | 22.27▼ | 21.62▲ | 15.37▲ |
| MA100 | 21.78▼ | 22.36▼ | 22.61▼ | 21.97▼ | 15.01▲ |
| MA200 | 22.02▼ | 22.67▼ | 21.38▲ | 16.58▲ | 17.90▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | 0.003▲ | -0.033▼ | -0.122▼ | -0.372▼ |
| RSI | 55.368▲ | 44.970▼ | 40.442▼ | 48.344▼ | 58.450▲ |
| STOCH | 47.529 | 42.933 | 26.720 | 22.161 | 41.066 |
| WILL %R | -21.053▲ | -57.346 | -70.297 | -87.772▼ | -50.508 |
| CCI | 77.638 | -1.407 | -58.301 | -103.342▼ | 5.425 |
|
Saturday, February 28, 2026 02:27 PM
Arcus Biosciences (NYSE:RCUS) used its fourth-quarter and full-year 2025 earnings call to highlight updated clinical data for its lead oncology program, casdatifan, and to outline near-term plans for ...
|
|
Wednesday, February 25, 2026 04:05 PM
Cash Position: $1 billion at the end of Q4 2025, up from $841 million at the end of Q3 2025. Q4 Revenue: $33 million, compared to $26 million in Q3 2025. R&D Expenses: $121 million for Q4 2025, down ...
|
|
Wednesday, February 25, 2026 07:01 AM
At least two additional data presentations for casdatifan are expected in 2026: updated data for casdatifan plus cabozantinib and initial data in early-line kidney cancer In addition to the ongoing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/03/26 | 21.69 | 22.285 | 21.23 | 21.68 | 378,908 |
| 20/03/26 | 22.46 | 22.745 | 21.64 | 21.64 | 4,158,044 |
| 19/03/26 | 21.91 | 22.86 | 21.71 | 22.43 | 826,458 |
| 18/03/26 | 22.50 | 22.50 | 21.92 | 22.21 | 822,282 |
| 17/03/26 | 22.52 | 23.16 | 22.315 | 22.59 | 598,825 |
| 16/03/26 | 22.56 | 23.035 | 22.32 | 22.45 | 1,099,015 |
| 13/03/26 | 22.71 | 23.06 | 21.69 | 21.97 | 1,173,168 |
| 12/03/26 | 23.69 | 24.18 | 22.62 | 22.70 | 1,147,249 |
| 11/03/26 | 24.02 | 24.91 | 23.71 | 24.42 | 1,348,639 |
| 10/03/26 | 23.18 | 24.70 | 22.99 | 24.56 | 1,562,457 |
|
|
||||
|
|
||||
|
|